tuberculosis
T Cell Receptor Repertoire Analysis Points to Potential Tuberculosis Vaccine Targets
Based on sequencing data, researchers cataloged T-cell receptors and identified the epitopes they target in people exposed to Mycobacterium tuberculosis.
LumiraDx Gets $14.2M in Gates Foundation Grants to Develop Point-of-Care Molecular TB Test
The test, which is being designed for use with the company's LumiraDx point-of-care platform, would be the first molecular test to run on the system.
Cowen Upgrades PerkinElmer Stock to Outperform
Analyst Max Masucci said the firm is expected to generate at least $3.21 billion in COVID-19-related revenues, while he lowered the stock price target to $164 per share.
Illumina, GenoScreen Partner to Comarket Genomic Testing for Multidrug-Resistant TB
The firms will comarket Illumina next-generation sequencing reagents with GenoScreen's Deeplex Myc-TB NGS-based test for antibiotic resistance in TB.
PBD Biotech Gains £2.4M Investment for TB Blood Test Development
The firm's blood-based Actiphage assay could help identify individuals with latent tuberculosis that could develop into disease and help doctors direct interventions.